Kevin A Webster

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice

M. Farrell, D. Weinshenker, J. Ritchie, 2018, Scientific Reports.